EN DE

Wang On Group (1222) Fair Value & Analysis

Industrials · HK · Market cap HK$298M

WO Wang On Group 1222 · HK
PriceHK$0.0210
Fair ValueHK$0.0218
Upside+3.8%
Quality53/100
Watch Wang On Group for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Loss-making · -50.1% net margin
Moderate debt · generates free cash flow
Mixed vs. peers (4/10)
Narrow moat 0/100
Evidence: Low Range HK$0.0199 – HK$0.0242 Share as image

Fair value as of: Aug 13, 2026

From 3 valuation models · updated 2 days ago

Fair value updated Aug 13, 2026, revised from HK$0.0237 to HK$0.0218 (−8.2%) since Aug 5, 2026. Share price −12.5% over the past month.

A solid business, currently priced close to our fair value.

What matters now

  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

HK$0.0794 HK$0.0180 Fair Value HK$0.0218 Jan 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range HK$0.0180 – HK$0.0794 · fair‑value band HK$0.0199 – HK$0.0242 · the HK$0.0210 price screens below the HK$0.0218 fair value. Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Wang On Group (1222) currently trades at HK$0.0210, while our model-based Fair Value estimate is HK$0.0218, implying the stock looks roughly 3.8% fairly valued today. The Quality Score stands at 53/100 (solid quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.

Over the trailing twelve months, Wang On Group generated revenue of HK$2.7B at a net margin of -50.1%. Revenue declined 1.8% year over year. It earns a return on equity of -25.5%. Net debt stands at HK$3.2B. Fundamentals as of Aug 13, 2026

Our scenario range runs from HK$0.0199 (bear case) to HK$0.0242 (bull case); at HK$0.0210, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 34% below its 52-week high and 11% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at 11% fair-value upside, at 4%, 1222 screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF HK$0.5300 HK$0.8300 HK$1.21 80
Rev-Margin DCF HK$0.5400 HK$0.9600 HK$1.47 74
NCAV (Graham) HK$0.1300 HK$0.1700 HK$0.2600 50
All 3 models by family
Asset-Based
NCAV (Graham) HK$0.1300 HK$0.1700 HK$0.2600 50
Growth DCF
Growth DCF HK$0.5300 HK$0.8300 HK$1.21 80
Rev-Margin DCF HK$0.5400 HK$0.9600 HK$1.47 74

Widest divergence: Growth DCF (HK$0.8300) versus Asset-Based (HK$0.1700). Highest evidence: Growth DCF (80).

Notify me when 1222 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) HK$2.7B
Revenue growth (YoY) -1.8%
Net margin -50.1%
Return on equity -25.5%
Free cash flow HK$1.1B FY2025
Operating margin -10.4%
More key figures
EPS growth (YoY) -25.6%
Net debt HK$3.2B FY2026

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 53/100

Of which business quality 56 · Market factors (momentum, volatility) 35

Profitability 3
Margins and returns on capital today
Quality Growth 43
Are margins and returns improving?
Cashflow 100
Earnings quality: real cash, not paper profit
Fin. Strength 34
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 44
Calm price path (market factor)
Momentum 39
Price trend over the last 3–12 months (market factor)
52W Momentum 20
Distance to the 52-week high (market factor)
Net Issuance 83
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Wang On Group Limited, an investment holding company, primarily engages in the property development and investment activities in Hong Kong, Mainland China, Macau, and internationally. It operates through Property Development, Property Investment, Fresh Markets, Pharmaceutical, and Treasury Management segments.

Full company description

Wang On Group Limited, an investment holding company, primarily engages in the property development and investment activities in Hong Kong, Mainland China, Macau, and internationally. It operates through Property Development, Property Investment, Fresh Markets, Pharmaceutical, and Treasury Management segments. The company invests in industrial and commercial premises, and residential units for rental or for sale; and invests in debt and other securities. It also involved in the provision of finance; management and sub-licensing of fresh markets; butchery business, which includes management of properties in agricultural produce exchange markets; and production and sale of Chinese and Western pharmaceutical, health food, and personal healthcare products under the Wai Yuen Tong, Madame Pearl's, and Pearl's brand names. In addition, the company involved in asset management, money lending, sale of pork, and property management businesses, as well as offers treasury management, management and financial services. Wang On Group Limited was founded in 1987 and is headquartered in Kowloon Bay, Hong Kong.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Wang On Group reported revenue of HK$2.6B in FY2026 versus HK$1.9B in FY2022, a compound +9.1%/yr. Reported net income was −HK$804M in FY2026.

Growth Quality 43/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2026)
HK$2.6B
Latest YoY
−4.0%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−10.0%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+6.5%
Avg. growth/yr (26Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+8.2%
Revenue +9.1%/yr
FY22 HK$1.9B
FY23 HK$3.6B
FY24 HK$2.0B
FY25 HK$2.7B
FY26 HK$2.6B
Net income
FY22 −HK$305M
FY23 HK$12.8M
FY24 −HK$754M
FY25 −HK$922M
FY26 −HK$804M

Watch 1222: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Wang On Group Fair Value". https://www.fairvalue-calculator.com/stock/1222

Peer Group

Conglomerates · 385 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 55 · Above median
Fair Value upside −5% · Above median
Return on assets -3% · Bottom 25%
Net margin (TTM) -50% · Bottom 25%
Operating margin (TTM) -10% · Bottom 25%
Revenue growth -2% · Below median
Debt / equity 0.94× · Higher than 75% of peers

Valuation Multiples vs Conglomerates median · lower = cheaper

P/S (TTM) 0.01× · Cheaper than 75% of peers
P/FCF 0.0× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 27 · sector 27
FUTURE 0 · sector 17
PAST 0 · sector 18
HEALTH 53 · sector 89
DIVIDEND 0 · sector 46

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Conglomerates stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
ITOCHU Corporation ITOCHU19 7.20 THB 14.40 THB +100%
SK Inc 034730 553,000 KRW 615,077 KRW +11%
PT Astra International Tbk, ASII 4,860 IDR 9,720 IDR +100%
Koç Holding KCHOL 205.80 TRY 182.26 TRY -11%
SRF Limited SRF ₹2,585 ₹859.71 -67%
Empresas Copec S.A COPEC 6,030 CLP 10,809 CLP +79%
Posco International Corporation 047050 54,300 KRW 71,119 KRW +31%
Tube Investments of India Limited TIINDIA ₹2,839 ₹723.80 -75%
Doosan Corporation 000155 436,000 KRW 93,413 KRW -79%
Thermax Limited THERMAX ₹4,002 ₹1,343 -66%

Compare Wang On Group with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Wang On Group (1222) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of HK$0.0218 versus a price of HK$0.0210, about +4% (fairly valued).
What is the fair value of 1222?
Our model-based fair value for Wang On Group is HK$0.0218 (as of Aug 13, 2026), built from audited fundamentals. The current price is HK$0.0210.
What is the quality score of 1222?
Wang On Group has a Quality Score of 53/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Wang On Group (1222)?
Wang On Group reported trailing-twelve-month revenue of about HK$2.7B (latest available figure, as of Aug 13, 2026).
What is the net profit margin of 1222?
The net profit margin of Wang On Group is about -50.1%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Wang On Group and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.